Chicago: New Technologies Help Drugs Cross Blood-Brain Barrier
said.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=2286 Alzheimer's Disease
379 RESULTS
You searched Esther
Sort By:
said.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=2286 Alzheimer's Disease
could be a pharmacological way to unleash the CatB-dependent Aβ degradation,” she said.—Esther Landhuis
think we need to pay attention to factors that are important to trial participants.”—Esther Landhuis
below).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2713 Aging Growth Factors and Growth
to the list of potential mechanisms that go awry in aging and AD.—Esther Landhuis None
venture capitalist.—Esther Landhuis. Q&A With Claude Wischik. Questions by Esther Landhuis. Q: The
neuropsychological tests.—Esther Landhuis. This is Part 1 of a four-part series. See Part 2. None
trial could start next year, Roses told ARF.—Esther Landhuis. None
2007), Nixon noted (see full comment below).—Esther Landhuis None
aggressively pursued,” Blurton-Jones said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2523
and NMDA receptor antagonists.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1879
findings. Forthcoming analyses should shed light on this issue, he said.—Esther Landhuis. None
wakefulness, see Robertson, 2009).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2035
researchers to “look over a larger volume of tissue with better temporal resolution.”—Esther Landhuis None
that is.—Esther Landhuis and Gabrielle Strobel. None http://www.alzforum.org/new/detail.asp?id=1893